1. Home
  2. RKDA vs APVO Comparison

RKDA vs APVO Comparison

Compare RKDA & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$0.44

Market Cap

1.1M

Sector

Industrials

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$1.82

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
APVO
Founded
2002
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
4.3M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
RKDA
APVO
Price
$0.44
$1.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.1K
128.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
66.92
0.13
EPS
N/A
N/A
Revenue
$4,858,000.00
$3,114,000.00
Revenue This Year
$61.67
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.50
52 Week High
$6.71
$10.70

Technical Indicators

Market Signals
Indicator
RKDA
APVO
Relative Strength Index (RSI) 39.04 29.48
Support Level $0.39 $1.64
Resistance Level $0.55 $4.84
Average True Range (ATR) 0.04 0.16
MACD 0.00 0.05
Stochastic Oscillator 24.48 17.24

Price Performance

Historical Comparison
RKDA
APVO

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: